, Tracking Stock Market Picks
Enter Symbol:
Amylin Pharmaceuticals, Inc. (AMLN) [hlAlert]


Amylin Pharmaceuticals, Inc. (AMLN) downgraded to Hold by Lazard Capital

Posted on: Monday,  Mar 3, 2008  10:25 AM ET by Lazard Capital

Lazard Capital rated Hold Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) on 03/03/2008. Previously Lazard Capital rated Buy Amylin
Pharmaceuticals, Inc. (NASDAQ: AMLN) on 09/10/2007., when the stock price was $48.95. Since then, Amylin Pharmaceuticals, Inc. has lost 48.64% of its value until Lazard Capital rated AMLN Buy on 03/03/2008, when the price was $25.14. .

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN injection and BYETTA injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over one thousand five hundred employees nationwide.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Our goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Our industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/2/2008 8:25 AM Buy
as of 12/24/2008
1 Week up  10.51 %
1 Month down  -8.31 %
3 Months up  3.40 %
1 YTD up  3.68 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/3/2008 10:25 AM Hold
9/10/2007 9:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy